ARCHIVES

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

This article is from The Cancer Letter archive.

Vol. 18 No. 09 | February 28, 1992

Download PDF Visit The Full Archive

Related Articles

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

June 18, 1993

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

In Brief: NIH Peer Review Reorganization Proposed By Advisory Panel; Comments Sought

September 3, 1999

Clinton Declares Month of April Cancer Control Month

April 11, 1997

Decision Delayed On Breast Cancer Study Until After Consensus Meeting

July 5, 1985